Assenagon Asset Management S.A. Acquires 194,788 Shares of Masimo Co. (NASDAQ:MASI)

Assenagon Asset Management S.A. lifted its stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 916.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 216,051 shares of the medical equipment provider's stock after buying an additional 194,788 shares during the quarter. Assenagon Asset Management S.A. owned about 0.40% of Masimo worth $35,713,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. FMR LLC grew its holdings in Masimo by 41.2% in the 3rd quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider's stock valued at $900,860,000 after buying an additional 1,970,883 shares in the last quarter. Thrivent Financial for Lutherans boosted its position in shares of Masimo by 42.1% in the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider's stock valued at $153,314,000 after acquiring an additional 360,497 shares during the period. Point72 Asset Management L.P. boosted its position in shares of Masimo by 107.8% in the second quarter. Point72 Asset Management L.P. now owns 677,677 shares of the medical equipment provider's stock valued at $85,347,000 after acquiring an additional 351,523 shares during the period. Westfield Capital Management Co. LP grew its stake in shares of Masimo by 23.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider's stock valued at $185,869,000 after acquiring an additional 262,370 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Masimo by 45.9% during the second quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider's stock worth $66,201,000 after acquiring an additional 165,257 shares during the period. Institutional investors own 85.96% of the company's stock.

Masimo Price Performance

Shares of Masimo stock traded up $2.35 during trading on Friday, reaching $172.29. 616,441 shares of the company's stock were exchanged, compared to its average volume of 542,867. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $180.97. The company has a market cap of $9.22 billion, a P/E ratio of 118.82 and a beta of 1.01. The firm's 50-day moving average price is $169.03 and its 200 day moving average price is $139.75.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.14. The company had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm's quarterly revenue was up 5.4% compared to the same quarter last year. During the same period last year, the company posted $0.63 EPS. As a group, research analysts anticipate that Masimo Co. will post 4.03 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Wells Fargo & Company boosted their price objective on shares of Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. Stifel Nicolaus reissued a "buy" rating and set a $190.00 price target (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. BTIG Research raised their price objective on Masimo from $166.00 to $170.00 and gave the stock a "buy" rating in a research note on Monday, October 14th. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a research report on Thursday. Finally, Raymond James increased their target price on Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a report on Friday, December 27th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $179.67.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.